Download Full Text (10.4 MB)


  • Early Detection of Melanoma Spread May Increase Survival Benefits of Adjuvant Therapy
  • No Easy Answers: Women at Increased Risk for Breast Cancer Face Difficult Choices
  • DiaLog: Understanding Risk: A Prerequisite for Making Informed Decisions, by Gordon B. Mills, MD, PhD, Chairman, Department of Molecular Therapeutics
  • House Call: Looking for Trouble: How to Spot Signs of Melanoma
  • Protocols: Melanoma Clinical Trials
  • Biochemotherapy Means Hope for Patients with Advanced Melanoma

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Publication Date



The University of Texas MD Anderson Cancer Center


Houston, Texas


Lee, Jeffrey; Ross, Merrick I.; Emerson, Marcia; Gershenwald, Jeffrey E.; Bedikian, Agop Y.; Eton, Omar; Savary, Cherylyn; Bevers, Therese; Mills, Gordon B.; Rieger, Paula Trahan; Graham, Christie; Hodges, Cynthia; Melanoma; Chemotherapy, Adjuvant; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Radioimmunodetection; Clinical Trials as Topic; Cisplatin; Vinblastine; Dacarbazine; Interferons; Interleukin-2; Capillary Leak Syndrome; Neoadjuvant Therapy; Oligonucleotides, Antisense; Paclitaxel; Metalloproteases; 7-methylthiomethylpaclitaxel; Taxoids; endoplasmin; Membrane Glycoproteins; Molecular Chaperones; Peptides; T-Lymphocytes; Enzyme-Linked Immunospot Assay; Skin Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Basal Cell; Melanocytes; Dysplastic Nevus Syndrome; Sunscreening Agents; Breast Neoplasms; Early Detection of Cancer; Biopsy; Tamoxifen; Risk; Decision Making.


History of Science, Technology, and Medicine | Oncology

Conditions Governing Access


OncoLog, Volume 45, Number 05, May 2000